Tandem Diabetes (TNDM) Misses Q1 EPS by 4c, Affirms Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Tandem Diabetes Care Reports First Quarter 2015 Financial Results
April 30, 2015 4:15 PM EDTSAN DIEGO, April 30, 2015 /PRNewswire/ -- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® and t:flex Insulin Pumps, today reported its financial results for the quarter ended March 31, 2015.
In comparing the first quarter of 2015 to the same period of 2014:
Sales grew 53 percent to $12.3 million from $8.1 million t:slim Pump shipments grew 44 percent to 2,487 pumps from 1,723 pumps"Our investment in resources to build the foundation of our business is driving year-over-year revenue growth and improving... More
